LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 18.82 | 17.25 | 1 | 800 | 0.0012 | -0.4022 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 18.82 | 17.25 | 1561 | 800 | 1.9500 | 1.2564 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 20.79 | 17.25 | 9 | 1001 | 0.0090 | -0.1051 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 20.79 | 17.25 | 1278 | 1001 | 1.2759 | 1.0849 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 20.79 | 17.25 | 1 | 1001 | 0.0010 | -0.3849 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 20.79 | 17.25 | 1679 | 1001 | 1.6762 | 1.1843 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 22.76 | 17.25 | 8 | 1193 | 0.0067 | -0.1181 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 22.76 | 17.25 | 1369 | 1193 | 1.1470 | 1.0454 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 22.76 | 17.25 | 1 | 1193 | 0.0008 | -0.3725 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 22.76 | 17.25 | 1793 | 1193 | 1.5022 | 1.1377 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 24.73 | 17.25 | 11 | 1290 | 0.0085 | -0.0697 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 24.73 | 17.25 | 1488 | 1290 | 1.1533 | 1.0464 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 24.73 | 17.25 | 1 | 1290 | 0.0008 | -0.3672 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 24.73 | 17.25 | 1931 | 1290 | 1.4967 | 1.1338 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 26.70 | 17.25 | 7 | 1466 | 0.0048 | -0.1313 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 26.70 | 17.25 | 1579 | 1466 | 1.0766 | 1.0232 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 26.70 | 17.25 | 1 | 1466 | 0.0007 | -0.3587 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 26.70 | 17.25 | 2080 | 1466 | 1.4181 | 1.1120 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 28.67 | 17.25 | 17 | 1653 | 0.0103 | -0.0022 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 28.67 | 17.25 | 1730 | 1653 | 1.0465 | 1.0139 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 28.67 | 17.25 | 1 | 1653 | 0.0006 | -0.3512 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 28.67 | 17.25 | 2226 | 1653 | 1.3465 | 1.0925 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 30.64 | 17.25 | 20 | 1887 | 0.0106 | 0.0221 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 30.64 | 17.25 | 1863 | 1887 | 0.9871 | 0.9962 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 30.64 | 17.25 | 1 | 1887 | 0.0005 | -0.3433 | MN20160310_N02 | J17 |